Navigation Links
PDL BioPharma Receives Letter from Genentech Relating to European Patents
Date:8/13/2010

INCLINE VILLAGE, Nev., Aug. 13 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

Forward-Looking Statements

This press release contains forward-looking statements. Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from those, express or implied, in these forward-looking statements. Factors that may cause differences between current expectations and actual results include, but are not limited to, the following:

  • The expected rate of growth in royalty-bearing product sales by PDL's existing licensees;
  • The relative mix of royalty-bearing Genentech products manufactured and sold outside the U.S. versus manufactured or sold in the U.S.;
  • The ability of our licensees to receive regulatory approvals to market and launch new royalty-bearing products and whether such products, if launched, will be commercially successful;
  • Changes in any of the other assumptions on which PDL's projected royalty revenues are based;
  • The outcome of pending litigation or disputes; and
  • The failure of licensees to comply with existing license agreements, including any failure to pay royalties due.

Other factors that may cause PDL's actual results to differ materially from those expressed or implied in the forward-looking statements in this press release are discussed in PDL's filings with the SEC, including the "Risk Factors" section of its annual and quarterly reports filed with the SEC. Copies of PDL's filings with the SEC may be obtained at the "Investors" section of PDL's website at www.pdl.com. PDL expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statem
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CeNeRx BioPharma Completes $13 Million Series C Financing
2. Almac Launch Biomarkers for Biopharma
3. Health Outcomes Data Essential to Biopharmaceutical Sales Process
4. Waters Corporation and NIBRT Partner to Bring Greater Control and Predictability to Biopharmaceutical Processing
5. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
6. Kincannon & Reed Names David G. Jensen as Managing Director, Biopharma Life Sciences
7. Tianyin to Present at 5th Annual Biomedical Forum by Sino American BioPharmaceutical Association
8. R&D Investment by U.S. Biopharmaceutical Companies Increases to Record $65.3 Billion, Study Finds
9. PDL BioPharma To Hold Annual Meeting of Stockholders on June 9, 2010
10. R&D Investment by U.S. Biopharmaceutical Companies Remains Strong Despite Ongoing Economic Challenges
11. Keryx Biopharmaceuticals to Present at the 22nd Annual ROTH OC Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 ... of the "Physician Office Laboratory Markets, 3rd ... This report, Physician Office Laboratory Markets is ... the IVD industry. Physician office laboratories are diverse ... simply perform reimbursable, in-office pregnancy and glucose tests. ...
(Date:9/23/2014)... , Sept. 23, 2014 The Pennsylvania State ... Sat., Sept. 27, as part of National Prescription Drug ... questions asked. Take-Back Day is a national ... Administration (DEA), aimed at encouraging the public to dispose ... prone to abuse and theft. From 10 ...
(Date:9/23/2014)... 23, 2014 Research and Markets ... Vaccine Production Markets" report to their offering. ... and vaccines - including products to treat cancer, diabetes, ... challenges during the final stages of clinical drug testing ... to risk production capital to upscale while anticipating FDA ...
Breaking Medicine Technology:Physician Office Laboratory Markets, 3rd Edition 2Physician Office Laboratory Markets, 3rd Edition 3Biopharmaceutical and Vaccine Production Markets 2Biopharmaceutical and Vaccine Production Markets 3
... Top-line Data to be Released Concurrent with November 9 AHA Data ... ... (Nasdaq: VIAP ), a biotechnology company focused on the development of,compounds ... last patient visit in its Phase 2 acute coronary,syndrome (ACS) study, including ...
... and Efficacy of ORMD 0801, Oral Insulin Capsule, ... on Type 1 ... http://www.oramed.com ), a developer,of oral delivery systems, announced today that it has ... 1 diabetics at the,Hadassah University Medical Center in Jerusalem, Israel., Oramed,s ...
Cached Medicine Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 4Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics 2
(Date:9/23/2014)... A new analysis of published studies found that ... cancer versus benign disease in regions where infections ... of lung lesions suspicious for cancer could lead ... additional potential complications and mortality. , Histoplasmosis ... that are often concentrated in bird droppings and ...
(Date:9/23/2014)... California, Davis, and Academia Sinica, the preeminent academic ... entered into a collaborative agreement to develop a ... cutting-edge research with opportunities to translate innovative technologies ... The agreement was signed Sept.12 in Taipei by ... Davis and President Chi-Huey Wong of Academia Sinica. ...
(Date:9/23/2014)... From first-hand experience, Matthew O'Farrell knows ... how it can be treated. , A medically retired ... 2006. His platoon sustained multiple attacks resulting in five ... with combat-related PTSD and honorably discharged from the Army. ... had distanced myself from my friends and family,” recalled ...
(Date:9/23/2014)... As a consumer in today’s world, ... It’s difficult to trust testimonials that are supplied by ... manipulate their customers into saying anything. , Consumer advocacy ... to lack in depth coverage on a particular market ... to fix this issue and focus on exposing the ...
(Date:9/23/2014)... HealthDay Reporter TUESDAY, Sept. 23, 2014 (HealthDay ... breast milk is more likely than a blood transfusion to ... a new study finds. The researchers evaluated more than ... weighed 3.3 pounds or less and many who were born ... whether breast milk or transfusions carried the bigger risk. Infants ...
Breaking Medicine News(10 mins):Health News:Study questions accuracy of lung cancer screens in some geographic regions 2Health News:Academia Sinica, UC Davis sign agreement on exchanges and tech transfer 2Health News:Virtual Reality software to help treat PTSD 2Health News:Virtual Reality software to help treat PTSD 3Health News:Consumer Health Reports Debuts Revolutionary Review Website 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 2Health News:Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds 3
... Former Steeler Robin Cole to Appear , , ... be Saturday, August 8, as Experience LEBO and Miller Lite present ... party event, from 8 p.m. to midnight. , , ... to literally party in the street-- Rt. 19/Washington Road closes to vehicular traffic ...
... , FERNDALE, Wash., July 28 Nearly 64 ... vitamin D - a nutrient found to support the immune system, bone strength, ... , manufacturers of a liquid vitamin D3 supplement. , , ... aware that sunscreen, even at SPF15, blocks more than 90 percent of the ...
... , , , ... health care providers and nonprofit health plans, announced today that it ... more than 700 nonprofit agencies nationwide in the second quarter of ... access to high-quality care to uninsured and underserved communities, healthy food ...
... , , LOS ANGELES, ... of next generation digital media protection and intelligence solutions, today ... technology platform to ensure network protection and data security for ... companies, pharmaceutical companies, hospitals, physician practices, and more. In ...
... study by researchers at the Georgetown,s Lombardi Comprehensive Cancer Center ... urine of children with acute lymphoblastic leukemia (ALL), a cancer ... age. The findings are published in the August issue ... caution that these findings should not be seen as cause-and-effect, ...
... , EAST RUTHERFORD, N.J., July 28 Cambrex Corporation (NYSE: CBM ) announced ... closes. , , The Company will host a conference call to discuss the ... Second Quarter 2009 Earnings Conference Call, ... 5, 2009 at 8:30 a.m. Eastern Time, Dial-in: ...
Cached Medicine News:Health News:Mt. Lebanon Comes Alive Saturday, August 8th with ULTRAparty 2Health News:Survey Finds 64% of Americans Unaware Sunscreen Inhibits Vitamin D Production 2Health News:Survey Finds 64% of Americans Unaware Sunscreen Inhibits Vitamin D Production 3Health News:Kaiser Permanente Approves $11 Million in Community Benefit Grants 2Health News:Kaiser Permanente Approves $11 Million in Community Benefit Grants 3Health News:Kaiser Permanente Approves $11 Million in Community Benefit Grants 4Health News:Kaiser Permanente Approves $11 Million in Community Benefit Grants 5Health News:Nexicon Technology to Protect Healthcare Industry 2Health News:Nexicon Technology to Protect Healthcare Industry 3Health News:Nexicon Technology to Protect Healthcare Industry 4Health News:Nexicon Technology to Protect Healthcare Industry 5Health News:Common household pesticides linked to childhood cancer cases in Washington area 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: